Infection Prevention and Control (CPD Accredited)

The global market on infectious diseases encompasses the development, production, and distribution of diagnostics, treatments, vaccines, and preventive measures aimed at combating infectious diseases worldwide. It includes sectors such as diagnostics (e.g., PCR tests, rapid diagnostic kits), therapeutics (e.g., antibiotics, antivirals, antifungals), and vaccines (e.g., for diseases like COVID-19, influenza, malaria). The market is driven by the rising global burden of infectious diseases, increasing antimicrobial resistance (AMR), advancements in molecular diagnostics and vaccines, and efforts to control emerging diseases (e.g., COVID-19, Zika, and Ebola). Key players include major pharmaceutical companies, diagnostic firms, and global health organizations. The market is growing rapidly, especially in Asia-Pacific and Africa, due to rising healthcare investments and increasing disease incidences in these regions. However, challenges such as vaccine hesitancy and access to healthcare in low-income regions remain significant obstacles.